Development of tau aggregation inhibitors for alzheimer's disease

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847 · see citing works

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · see citing works

Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo

Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · see citing works

Atomic structures of amyloid cross-β spines reveal varied steric zippers

Sawaya, M. R., Sambashivan, S., Nelson, R. A., Ivanova, M. I., Sievers, S. A., Apostol, M. I., Thompson, M. J., Balbirnie, M., Wiltzius, J. J. W., McFarlane, H. T., et al. (2007) · Nature · doi:10.1038/nature05695 · Cited by 2,279 · see citing works

Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders

Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174 · see citing works

Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · see citing works

MODELS OF AMYLOID SEEDING IN ALZHEIMER'S DISEASE AND SCRAPIE: Mechanistic Truths and Physiological Consequences of the Time-Dependent Solubility of Amyloid Proteins

Harper, J. D., & Lansbury, P. T. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.385 · Cited by 1,652 · see citing works

Bioisosterism: A Rational Approach in Drug Design

Patani, G. A., & LaVoie, E. J. (1996) · Chemical Reviews · doi:10.1021/cr950066q · Cited by 1,344 · see citing works

Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif ( ³⁰⁶ VQIVYK ³¹¹ ) forming β structure

von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E.-M., & Mandelkow, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5129 · Cited by 1,021 · see citing works

Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease

KIDD, M. (1963) · Nature · doi:10.1038/197192b0 · Cited by 1,012 · see citing works

Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism

Porat, Y., Abramowitz, A., & Gazit, E. (2005) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00318.x · Cited by 994 · see citing works

Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease

Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987 · see citing works

Amyloid ion channels: A common structural link for protein-misfolding disease

Quist, A. P., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B. L., Ghiso, J. A., & Lal, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502066102 · Cited by 982 · see citing works

Tau is essential to β-amyloid-induced neurotoxicity

Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807 · see citing works

Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers

Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., et al. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-18 · Cited by 773 · see citing works

The binding of thioflavin-T to amyloid fibrils: localisation and implications

Krebs, M. R. H., Bromley, E. H. C., & Donald, A. M. (2004) · Journal of Structural Biology · doi:10.1016/j.jsb.2004.08.002 · Cited by 756 · see citing works

Calculating log Poct from structures

Leo, A. J. (1993) · Chemical Reviews · doi:10.1021/cr00020a001 · Cited by 705 · see citing works

Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct

Necula, M., Kayed, R., Milton, S., & Glabe, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608207200 · Cited by 680 · see citing works

Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation.

Klunk, W. E., Pettegrew, J. W., & Abraham, D. J. (1989) · Journal of Histochemistry & Cytochemistry · doi:10.1177/37.8.2666510 · Cited by 625 · see citing works

A Specific Mechanism of Nonspecific Inhibition

McGovern, S. L., Helfand, B. T., Feng, B. Y., & Shoichet, B. K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030266r · Cited by 600 · see citing works

Alternative conformations of amyloidogenic proteins govern their behavior

Kelly, J. W. (1996) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(96)80089-3 · Cited by 589 · see citing works

Phosphorylation that Detaches Tau Protein from Microtubules (Ser262, Ser214) Also Protects It against Aggregation into Alzheimer Paired Helical Filaments

Schneider, A., Biernat, J., von Bergen, M., Mandelkow, E., & Mandelkow, E.-M. (1999) · Biochemistry · doi:10.1021/bi981874p · Cited by 564 · see citing works

Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.

Wischik, C. M., Edwards, P. C., Lai, R. Y., Roth, M., & Harrington, C. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11213 · Cited by 547 · see citing works

Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins

Taniguchi, S., Suzuki, N., Masuda, M., Hisanaga, S., Iwatsubo, T., Goedert, M., & Hasegawa, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408714200 · Cited by 540 · see citing works

Aromatic interactions in model systems

Waters, M. L. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00359-9 · Cited by 430 · see citing works

Imaging Aβ Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy-X04, a Systemically Administered Congo Red Derivative

Klunk, W. E., Bacskai, B. J., Mathis, C. A., Kajdasz, S. T., McLellan, M. E., Frosch, M. P., Debnath, M. L., Holt, D. P., Wang, Y., & Hyman, B. T. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.9.797 · Cited by 412 · see citing works

Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models

Cheng, I. H.-J., Scearce-Levie, K. A., Legleiter, J. A., Palop, J. J., Gerstein, H., Bien‐Ly, N., Puolivaöli, J., Lesné, S., Ashe, K. H., Muchowski, P. J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701078200 · Cited by 403 · see citing works

Rapid Assembly of Alzheimer-like Paired Helical Filaments from Microtubule-Associated Protein Tau Monitored by Fluorescence in Solution

Friedhoff, P., Schneider, A., Mandelkow, E., & Mandelkow�, E. (1998) · Biochemistry · doi:10.1021/bi980537d · Cited by 401 · see citing works

Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?

Lashuel, H. A., & Lansbury, P. T. (2006) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583506004422 · Cited by 398 · see citing works

The two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseases

Winklhofer, K. F., Tatzelt, J., & Haass, C. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601930 · Cited by 395 · see citing works

Tau aggregation is driven by a transition from random coil to beta sheet structure.

von Bergen, M., Barghorn, S., Biernat, J., Mandelkow, E., & Mandelkow, E. (2005) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2004.09.010 · Cited by 376 · see citing works

Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain

Klunk, W. E., Lopresti, B. J., Ikonomović, M. D., Lefterov, I. M., Koldamova, R. P., Abrahamson, E. E., Debnath, M. L., Holt, D. P., Huang, G.-F., Shao, L., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2990-05.2005 · Cited by 376 · see citing works

Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy

Hotta, N., Akanuma, Y., Kawamori, R., Matsuoka, K., Oka, Y., Shichiri, M., Toyota, T., Nakashima, M., Yoshimura, I., Sakamoto, N., et al. (2006) · Diabetes Care · doi:10.2337/dc05-2370 · Cited by 367 · see citing works

Anthraquinones Inhibit Tau Aggregation and Dissolve Alzheimer's Paired Helical Filaments in Vitro and in Cells

Pickhardt, M., Gažová, Z., von Bergen�, M., Khlistunova, I., Wang, Y., Hascher, A., Mandelkow, E., Biernat, J., & Mandelkow�, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410984200 · Cited by 334 · see citing works

Structure–activity Relationships of Amyloid Beta‐aggregation Inhibitors Based on Curcumin: Influence of Linker Length and Flexibility

Reinke, A. A., & Gestwicki, J. E. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00557.x · Cited by 330 · see citing works

Novel Therapeutic Approach for the Treatment of Alzheimer's Disease by Peripheral Administration of Agents with an Affinity to β-Amyloid

Matsuoka, Y., Saito, M., LaFrancois, J. J., Saito, M., Gaynor, K., Olm, V., Wang, L., Casey, E., Lu, Y., Shiratori, C., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00029.2003 · Cited by 324 · see citing works

Inositol Stereoisomers Stabilize an Oligomeric Aggregate of Alzheimer Amyloid β Peptide and Inhibit Aβ-induced Toxicity

McLaurin, J., Golomb, R., Jurewicz, A., Antel, J. P., & Fraser, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m906994199 · Cited by 265 · see citing works

The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates β-Amyloid-Induced Neurodegeneration

Park, S.-Y., & Ferreira, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1125-05.2005 · Cited by 262 · see citing works

Small-molecule aggregates inhibit amyloid polymerization

Feng, B. Y., Toyama, B. H., Wille, H., Colby, D. W., Collins, S. R., May, B. C. H., Prusiner, S. B., Weissman, J. S., & Shoichet, B. K. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.65 · Cited by 257 · see citing works

Congo red and thioflavin‐T analogs detect Aβ oligomers

Maezawa, I., Hong, H., Liu, R., Wu, C., Cheng, R. H., Kung, M., Kung, H. F., Lam, K. S., Oddo, S., LaFerla, F. M., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04972.x · Cited by 226 · see citing works

Highly Populated Turn Conformations in Natively Unfolded Tau Protein Identified from Residual Dipolar Couplings and Molecular Simulation

Mukrasch, M. D., Markwick, P. R. L., Biernat, J., von Bergen�, M., Bernadó, P., Griesinger, C., Mandelkow�, E., Zweckstetter, M., & Blackledge, M. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0690159 · Cited by 222 · see citing works

Tau-dependent microtubule disassembly initiated by prefibrillar β-amyloid

King, M. E., Kan, H.-M., Baas, P. W., Erişir, A., Glabe, C. G., & Bloom, G. S. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200605187 · Cited by 215 · see citing works

Tau Paired Helical Filaments from Alzheimer's Disease Brain and Assembled in Vitro Are Based on β-Structure in the Core Domain

Barghorn, S., Davies, P., & Mandelkow�, E. (2004) · Biochemistry · doi:10.1021/bi0357006 · Cited by 209 · see citing works

Supramolecular Structures of J-Aggregates of Carbocyanine Dyes in Solution

von Berlepsch, H., Böttcher, C., Ouart, A., Burger, C., Dähne, S., & Kirstein, S. (2000) · The Journal of Physical Chemistry B · doi:10.1021/jp000220z · Cited by 207 · see citing works

Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay

Heiser, V., Engemann, S., Bröcker, W., Dunkel, I., Boeddrich, A., Waelter, S., Nordhoff, E., Lurz, R., Schugardt, N., Rautenberg, S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182426599 · Cited by 205 · see citing works

The “Jaws” of the Tau-Microtubule Interaction

Mukrasch, M. D., von Bergen�, M., Biernat, J., Fischer, D., Griesinger, C., Mandelkow�, E., & Zweckstetter, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607159200 · Cited by 196 · see citing works

Imaging linear birefringence and dichroism in cerebral amyloid pathologies

Jin, L., Claborn, K. A., Kurimoto, M., Geday, M. A., Maezawa, I., Sohraby, F., Estrada, M. R., Kaminksy, W., & Kahr, B. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2534647100 · Cited by 192 · see citing works

Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease.

Klunk, W., Debnath, M., & Pettegrew, J. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90050-7 · Cited by 180 · see citing works

Curcumin‐Derived Pyrazoles and Isoxazoles: Swiss Army Knives or Blunt Tools for Alzheimer's Disease?

Narlawar, R., Pickhardt, M., Leuchtenberger, S., Baumann, K., Krause, S., Dyrks, T., Weggen, S., Mandelkow�, E., & Schmidt, B. (2007) · ChemMedChem · doi:10.1002/cmdc.200700218 · Cited by 174 · see citing works

Orally available compound prevents deficits in memory caused by the Alzheimer amyloid‐β oligomers

Townsend, M., Cleary, J. P., Mehta, T., Hofmeister, J. J., Lesné, S., O‘Hare, E., Walsh, D. M., & Selkoe, D. J. (2006) · Annals of Neurology · doi:10.1002/ana.21051 · Cited by 167 · see citing works

Structure of tau protein and assembly into paired helical filaments

Friedhoff, P., von Bergen�, M., Mandelkow, E., & Mandelkow, E. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00038-7 · Cited by 165 · see citing works

Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment

Estrada, L. D., & Soto, C. A. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779318262 · Cited by 162 · see citing works

Rhodanine‐Based Tau Aggregation Inhibitors in Cell Models of Tauopathy

Bulic, B., Pickhardt, M., Khlistunova, I., Biernat, J., Mandelkow, E., Mandelkow�, E., & Waldmann, H. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200704051 · Cited by 158 · see citing works

Conformation-dependent antibodies target diseases of protein misfolding

Glabe, C. C. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.08.009 · Cited by 154 · see citing works

Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice

Leroy, K., Bretteville, A., Schindowski, K., Gilissen, E., Authelet, M., De Decker, R., Yilmaz, Z., Buée, L., & Brion, J.-P. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070345 · Cited by 135 · see citing works

A Model for Structure-Dependent Binding of Congo Red to Alzheimer β-Amyloid Fibrils

Carter, D. B., & Chou, K.-C. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00164-4 · Cited by 131 · see citing works

Radioligand Development for PET Imaging of β-Amyloid (Aβ)-Current Status

Cai, L., Innis, R. B., & Pike, V. W. (2006) · Current Medicinal Chemistry · doi:10.2174/092986707779313471 · Cited by 128 · see citing works

Chemical Probes of UDP-Galactopyranose Mutase

Carlson, E. E., May, J. F., & Kiessling, L. L. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.06.007 · Cited by 126 · see citing works

Phenylthiazolyl-Hydrazide and Its Derivatives Are Potent Inhibitors of τ Aggregation and Toxicity in Vitro and in Cells

Pickhardt, M., Larbig, G., Khlistunova, I., Çoksezen, A., Meyer, B., Mandelkow, E., Schmidt, B., & Mandelkow�, E. (2007) · Biochemistry · doi:10.1021/bi700878g · Cited by 125 · see citing works

Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation.

Howlett, D. R., George, A. R., OWEN, D. E., Ward, R. V., & Markwell, R. E. (1999) · PubMed Central · Cited by 123 · see citing works

Phosphorylated tau and the neurodegenerative foldopathies

Kosik, K. S., & Shimura, H. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.10.011 · Cited by 123 · see citing works

Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer β-amyloid fibril formation

Howlett, D. R., George, A. R., OWEN, D. E., Ward, R. V., & Markwell, R. E. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3430419 · Cited by 119 · see citing works

Impact of amyloid imaging on drug development in Alzheimer's disease

Mathis, C. A., Lopresti, B. J., & Klunk, W. E. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.06.015 · Cited by 118 · see citing works

O3‐04–07: Tau aggregation inhibitor (TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks

Wischik, C. M., Bentham, P., Wischik, D., & Seng, K. M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.438 · Cited by 118 · see citing works

Structure of Core Domain of Fibril-Forming PHF/Tau Fragments

Inouye, H., Sharma, D., Goux, W. J., & Kirschner, D. A. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.070136 · Cited by 111 · see citing works

Ultrastructural characteristics of tau filaments in tauopathies: Immuno‐electron microscopic demonstration of tau filaments in tauopathies

Arima, K. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00669.x · Cited by 106 · see citing works

High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation

Crowe, A., Ballatore, C., Hyde, E. G., Trojanowski, J. Q., & Lee, V. M. ‐. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.056 · Cited by 101 · see citing works

Delineation of Positron Emission Tomography Imaging Agent Binding Sites on β-Amyloid Peptide Fibrils

Ye, L., Morgenstern, J. L., Gee, A. D., Hong, G., Brown, J., & Lockhart, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501285200 · Cited by 97 · see citing works

Hemin and related porphyrins inhibit β‐amyloid aggregation

Howlett, D., Cutler, P., Heales, S., & Camilleri, P. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01290-8 · Cited by 95 · see citing works

Cyanine Dye N744 Inhibits Tau Fibrillization by Blocking Filament Extension: Implications for the Treatment of Tauopathic Neurodegenerative Diseases

Necula, M., Chirita, C. N., & Kuret, J. (2005) · Biochemistry · doi:10.1021/bi050387o · Cited by 89 · see citing works

Towards an understanding of amyloidogenesis

Kelly, J. W. (2002) · Nature Structural Biology · doi:10.1038/nsb0502-323 · Cited by 88 · see citing works

Soluble oligomers from a non‐disease related protein mimic Aβ‐induced tau hyperphosphorylation and neurodegeneration

Vieira, M. N. N., Forny‐Germano, L., Saraiva, L. M., Sebollela, A. S., Martinez, A. M. B., Houzel, J., Felice, F. G. D., & Ferreira, S. T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04809.x · Cited by 85 · see citing works

Kinase activities increase during the development of tauopathy in htau mice

Kelleher, I., Garwood, C., Hanger, D. P., Anderton, B. H., & Noble, W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04930.x · Cited by 78 · see citing works

Screening for Inhibitors of Tau Polymerization

Pickhardt, M., von Bergen�, M., Gažová, Z., Hascher, A., Biernat, J., Mandelkow, E., & Mandelkow�, E. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585891 · Cited by 74 · see citing works

β-Sheet Breakers for Alzheimers Disease Therapy

Biéler, S., & Soto, C. A. (2004) · Current Drug Targets · doi:10.2174/1389450043345290 · Cited by 62 · see citing works

Screening for Inhibitors of Tau Protein Aggregation into Alzheimer Paired Helical Filaments: A Ligand Based Approach Results in Successful Scaffold Hopping

Larbig, G., Pickhardt, M., Lloyd, D. G., & Schmidt, B. (2007) · Current Alzheimer Research · doi:10.2174/156720507781077250 · Cited by 58 · see citing works

N-Phenylamine Derivatives as Aggregation Inhibitors in Cell Models of Tauopathy

Pickhardt, M., Biernat, J., Khlistunova, I., Wang, Y.-P., Gažová, Z., Mandelkow�, E., & Mandelkow�, E. (2007) · Current Alzheimer Research · doi:10.2174/156720507781788765 · Cited by 53 · see citing works

Predicting 10‐Year Care Requirements for Older People with Suspected Alzheimer's Disease

Kinosian, B. P., Stallard, E., Lee, J. H., Woodbury, M. A., Zbrozek, A. S., & Glick, H. A. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04720.x · Cited by 52 · see citing works

Identification of naturally occurring spirostenols preventing β-amyloid-induced neurotoxicity

Lecanu, L., Yao, W., Teper, G., Yao, Z., Greeson, J., & Papadopoulos, V. (2003) · Steroids · doi:10.1016/j.steroids.2003.09.007 · Cited by 48 · see citing works

Amyloid Inhibitors and β-Sheet Breakers

Soto, C. A., & Estrada, L. D. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_18 · Cited by 47 · see citing works

The conformational characteristics of Congo red, Evans blue and Trypan blue

Skowronek, M., Roterman, I., Konieczny, L., et al. (2000) · Computers & Chemistry · doi:10.1016/s0097-8485(99)00089-3 · Cited by 47 · see citing works

Congo red-stabilized intermediates in the λ light chain transition from native to molten state

Pierkarska, B., Skowronek, M., Rybarska, J., Stopa, B., Roterman, I., & Konieczny, L. (1996) · Biochimie · doi:10.1016/0300-9084(96)89503-4 · Cited by 44 · see citing works

Alzheimer’s β-Amyloid: Insights into Fibril Formation and Structure from Congo Red Binding

Inouye, H., & Kirschner, D. A. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_10 · Cited by 43 · see citing works

The Challenge of Inhibiting Aβ Polymerization

LeVine, H. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023370167 · Cited by 41 · see citing works

Research Article: The Use of Rigid, Fibrillar Congo Red Nanostructures for Scaffolding Protein Assemblies and Inducing the Formation of Amyloid‐like Arrangement of Molecules

Spólnik, P., Stopa, B., Piekarska, B., et al. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00589.x · Cited by 35 · see citing works

Inhibition of Tau Aggregation in Cell Models of Tauopathy

Khlistunova, I., Pickhardt, M., Biernat, J., et al. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018307 · Cited by 31 · see citing works

Potency of a tau fibrillization inhibitor is influenced by its aggregation state

Congdon, E. E., Necula, M., Blackstone, R. D., & Kuret, J. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.05.004 · Cited by 30 · see citing works

Potent inhibition of tau fibrillization with a multivalent ligand

Honson, N. S., Jensen, J. R., Darby, M. V., & Kuret, J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.166 · Cited by 26 · see citing works

Rhodanine‐Based Tau Aggregation Inhibitors in Cell Models of Tauopathy

Bulic, B., Pickhardt, M., Khlistunova, I., Biernat, J., Mandelkow, E., Mandelkow�, E., & Waldmann, H. (2007) · Angewandte Chemie · doi:10.1002/ange.200704051 · Cited by 22 · see citing works

In Vitro Preparation of Prefibrillar Intermediates of Amyloid-β and α-Synuclein

Lashuel, H. A., & Grillo‐Bosch, D. (2005) · Humana Press eBooks · doi:10.1385/1-59259-874-9:019 · Cited by 20 · see citing works

Park2-Null/Tau Transgenic Mice Reveal a Functional Relationship between Parkin and Tau

Guerrero, R., Navarro, P., Gallego, E., Ávila, J., de Yébenes, J. G., & Sánchez, M. P. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13206 · Cited by 16 · see citing works

The Plasma Membrane: A Target and Hurdle for the Development of Anti- A? Drugs?

Talaga, B. S. P. P., & Quere, B. S. P. L. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023338897 · Cited by 16 · see citing works

A beta oligomerization A Therapeutic Target for Alzheimers Disease

Howlett, D. R. (2001) · Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents · doi:10.2174/1568013013359140 · Cited by 4 · see citing works

Alzheimer’s disease: Clinical trials and drug development

Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217 · see citing works

Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models

Silva, M. C., Ferguson, F. M., Cai, Q., Donovan, K. A., Nandi, G., Patnaik, D., Zhang, T., Huang, H.-T., Lucente, D. E., Dickerson, B. C., et al. (2019) · eLife · doi:10.7554/elife.45457 · Cited by 283 · see citing works

Specific Knockdown of Endogenous Tau Protein by Peptide-Directed Ubiquitin-Proteasome Degradation

Chu, T.-T., Gao, N., Li, Q.-Q., Chen, P.-G., Yang, X.-F., Chen, Y.-X., Zhao, Y.-F., & Li, Y.-M. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.02.016 · Cited by 247 · see citing works

Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease

Dubey, T., & Chinnathambi, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108153 · Cited by 151 · see citing works

Rational therapeutic approaches to progressive supranuclear palsy

Stamelou, M., de Silva, R., Arias-Carrion, O., Boura, E., Hollerhage, M., Oertel, W. H., Muller, U., & Hoglinger, G. U. (2010) · Brain · doi:10.1093/brain/awq115 · Cited by 91 · see citing works

The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics

Pritchard, S. M., Dolan, P. J., Vitkus, A., & Johnson, G. V. W. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01273.x · Cited by 89 · see citing works

Newly Developed Drugs for Alzheimer’s Disease in Relation to Energy Metabolism, Cholinergic and Monoaminergic Neurotransmission

Korábečný, J., Nepovimová, E., Cikánková, T., Špilovská, K., Vašková, L., Mezeiová, E., Kuča, K., & Hroudová, J. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2017.06.034 · Cited by 64 · see citing works

γ-Secretase and its modulators: Twenty years and beyond

Xia, W. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.011 · Cited by 54 · see citing works

Liquid-liquid phase separation in Alzheimer’s disease

Fu, Q., Zhang, B., Chen, X., & Chu, L. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02407-3 · Cited by 33 · see citing works

Exploring the inhibitory effects of liquiritigenin against tau fibrillation and related neurotoxicity as a model of preventive care in Alzheimer’s disease

Yuan, X., Wang, Z., Zhang, L., Sui, R., & Khan, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.05.041 · Cited by 22 · see citing works

Structural Models of Amyloid‐Like Fibrils

Nelson, R. A., & Eisenberg, D. S. (2006) · Advances in protein chemistry · doi:10.1016/s0065-3233(06)73008-x · Cited by 209 · see citing works

Two-Step Nucleation of Amyloid Fibrils: Omnipresent or Not?

Auer, S., Ricchiuto, P., & Kashchiev, D. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.06.022 · Cited by 91 · see citing works

Common Fibril Structures Imply Systemically Conserved Protein Misfolding Pathways In Vivo

Annamalai, K., Liberta, F., Vielberg, M.-T., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201701761 · Cited by 72 · see citing works

Morphology and mechanical properties of multi-stranded amyloid fibrils probed by atomistic and coarse-grained simulations

Yoon, G., Lee, M., Kim, K., et al. (2015) · Physical Biology · doi:10.1088/1478-3975/12/6/066021 · Cited by 14 · see citing works

Are amyloid fibrils molecular spandrels?

Hane, F. T. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.09.048 · Cited by 12 · see citing works